blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3421464

EP3421464 - RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, AS WELL AS PREPARATION METHOD AND USE THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  30.09.2022
Database last updated on 14.09.2024
FormerThe patent has been granted
Status updated on  22.10.2021
FormerGrant of patent is intended
Status updated on  09.06.2021
FormerExamination is in progress
Status updated on  06.05.2020
FormerRequest for examination was made
Status updated on  05.07.2019
FormerThe application has been published
Status updated on  30.11.2018
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 16.10.2024 [2024/42]
Applicant(s)For all designated states
Beijing Tide Pharmaceutical Co., Ltd.
No.8 East Rongjing Street BDA
Beijing 100176 / CN
[2019/01]
Inventor(s)01 / Zhao, Yanping
No.8 East Rongjing Street BDA
Beijing 100176 / CN
02 / Wang, Hongjun
No.8 East Rongjing Street BDA
Beijing 100176 / CN
03 / Li, Gong
No.8 East Rongjing Street BDA
Beijing 100176 / CN
04 / Jiang, Yuanyuan
No.8 East Rongjing Street BDA
Beijing 100176 / CN
05 / Li, Xiang
No.8 East Rongjing Street BDA
Beijing 100176 / CN
06 / Zhou, Liying
No.8 East Rongjing Street BDA
Beijing 100176 / CN
07 / Liu, Yanan
No.8 East Rongjing Street BDA
Beijing 100176 / CN
 [2019/01]
Representative(s)Paulraj, Leonita Theresa, et al
AA Thornton IP LLP
8th Floor, 125 Old Broad Street
London EC2N 1AR / GB
[N/P]
Former [2021/47]Paulraj, Leonita Theresa, et al
A.A. Thornton & Co.
Octagon Point
5 Cheapside
London EC2V 6AA / GB
Former [2019/01]Paulraj, Leonita Theresa, et al
A.A. Thornton & Co.
10 Old Bailey
London EC4M 7NG / GB
Application number, filing date17194108.129.09.2017
[2019/01]
Priority number, dateWO2017CN9108630.06.2017         Original published format: PCT/CN2017/091086
[2019/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3421464
Date:02.01.2019
Language:EN
[2019/01]
Type: B1 Patent specification 
No.:EP3421464
Date:24.11.2021
Language:EN
[2021/47]
Search report(s)(Supplementary) European search report - dispatched on:EP21.12.2017
ClassificationIPC:C07D405/14
[2019/01]
CPC:
C07D403/14 (EP,KR,US); A61K31/501 (KR); A61K31/506 (EP,KR,US);
A61K31/517 (EP,US); A61K31/519 (EP,KR,US); A61K31/53 (EP,US);
A61P17/00 (KR); A61P37/00 (KR); A61P9/10 (KR);
C07D405/14 (EP,KR,US); C07D409/14 (EP,KR,US); C07D413/14 (EP,KR,US);
C07D417/14 (EP,KR,US); C07D471/04 (EP,KR,US); C07D487/04 (EP,KR,US);
C07D495/04 (EP,KR,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/32]
Former [2019/01]AL,  AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  RS,  SE,  SI,  SK,  SM,  TR 
TitleGerman:RHO-ASSOZIIERTE PROTEINKINASEHEMMER, PHARMAZEUTISCHE ZUSAMMENSETZUNG DAMIT SOWIE HERSTELLUNGSVERFAHREN UND VERWENDUNG DAVON[2019/01]
English:RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, AS WELL AS PREPARATION METHOD AND USE THEREOF[2019/01]
French:INHIBITEUR DE PROTÉINE KINASE ASSOCIÉE À RHO, COMPOSITION PHARMACEUTIQUE LE CONTENANT AINSI QUE SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION[2019/01]
Examination procedure28.06.2019Amendment by applicant (claims and/or description)
28.06.2019Examination requested  [2019/32]
28.06.2019Date on which the examining division has become responsible
11.05.2020Despatch of a communication from the examining division (Time limit: M04)
03.08.2020Reply to a communication from the examining division
16.11.2020Despatch of a communication from the examining division (Time limit: M04)
29.01.2021Reply to a communication from the examining division
10.06.2021Communication of intention to grant the patent
13.10.2021Fee for grant paid
13.10.2021Fee for publishing/printing paid
13.10.2021Receipt of the translation of the claim(s)
Opposition(s)25.08.2022No opposition filed within time limit [2022/44]
Fees paidRenewal fee
23.09.2019Renewal fee patent year 03
24.09.2020Renewal fee patent year 04
23.09.2021Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU29.09.2017
AL24.11.2021
AT24.11.2021
CY24.11.2021
CZ24.11.2021
DK24.11.2021
EE24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
IT24.11.2021
LT24.11.2021
LV24.11.2021
MC24.11.2021
MK24.11.2021
MT24.11.2021
PL24.11.2021
RO24.11.2021
RS24.11.2021
SE24.11.2021
SI24.11.2021
SK24.11.2021
SM24.11.2021
BG24.02.2022
NO24.02.2022
GR25.02.2022
IS24.03.2022
PT24.03.2022
[2024/42]
Former [2024/27]HU29.09.2017
AL24.11.2021
AT24.11.2021
CY24.11.2021
CZ24.11.2021
DK24.11.2021
EE24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
IT24.11.2021
LT24.11.2021
LV24.11.2021
MC24.11.2021
MK24.11.2021
PL24.11.2021
RO24.11.2021
RS24.11.2021
SE24.11.2021
SI24.11.2021
SK24.11.2021
SM24.11.2021
BG24.02.2022
NO24.02.2022
GR25.02.2022
IS24.03.2022
PT24.03.2022
Former [2024/21]HU29.09.2017
AL24.11.2021
AT24.11.2021
CY24.11.2021
CZ24.11.2021
DK24.11.2021
EE24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
IT24.11.2021
LT24.11.2021
LV24.11.2021
MC24.11.2021
PL24.11.2021
RO24.11.2021
RS24.11.2021
SE24.11.2021
SI24.11.2021
SK24.11.2021
SM24.11.2021
BG24.02.2022
NO24.02.2022
GR25.02.2022
IS24.03.2022
PT24.03.2022
Former [2024/18]HU29.09.2017
AL24.11.2021
AT24.11.2021
CZ24.11.2021
DK24.11.2021
EE24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
IT24.11.2021
LT24.11.2021
LV24.11.2021
MC24.11.2021
PL24.11.2021
RO24.11.2021
RS24.11.2021
SE24.11.2021
SI24.11.2021
SK24.11.2021
SM24.11.2021
BG24.02.2022
NO24.02.2022
GR25.02.2022
IS24.03.2022
PT24.03.2022
Former [2023/27]AL24.11.2021
AT24.11.2021
CZ24.11.2021
DK24.11.2021
EE24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
IT24.11.2021
LT24.11.2021
LV24.11.2021
MC24.11.2021
PL24.11.2021
RO24.11.2021
RS24.11.2021
SE24.11.2021
SI24.11.2021
SK24.11.2021
SM24.11.2021
BG24.02.2022
NO24.02.2022
GR25.02.2022
IS24.03.2022
PT24.03.2022
Former [2023/22]AL24.11.2021
AT24.11.2021
CZ24.11.2021
DK24.11.2021
EE24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
LT24.11.2021
LV24.11.2021
MC24.11.2021
PL24.11.2021
RO24.11.2021
RS24.11.2021
SE24.11.2021
SI24.11.2021
SK24.11.2021
SM24.11.2021
BG24.02.2022
NO24.02.2022
GR25.02.2022
IS24.03.2022
PT24.03.2022
Former [2023/01]AL24.11.2021
AT24.11.2021
CZ24.11.2021
DK24.11.2021
EE24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
LT24.11.2021
LV24.11.2021
PL24.11.2021
RO24.11.2021
RS24.11.2021
SE24.11.2021
SI24.11.2021
SK24.11.2021
SM24.11.2021
BG24.02.2022
NO24.02.2022
GR25.02.2022
IS24.03.2022
PT24.03.2022
Former [2022/49]AL24.11.2021
AT24.11.2021
CZ24.11.2021
DK24.11.2021
EE24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
LT24.11.2021
LV24.11.2021
PL24.11.2021
RO24.11.2021
RS24.11.2021
SE24.11.2021
SK24.11.2021
SM24.11.2021
BG24.02.2022
NO24.02.2022
GR25.02.2022
IS24.03.2022
PT24.03.2022
Former [2022/35]AT24.11.2021
CZ24.11.2021
DK24.11.2021
EE24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
LT24.11.2021
LV24.11.2021
PL24.11.2021
RO24.11.2021
RS24.11.2021
SE24.11.2021
SK24.11.2021
SM24.11.2021
BG24.02.2022
NO24.02.2022
GR25.02.2022
IS24.03.2022
PT24.03.2022
Former [2022/34]AT24.11.2021
EE24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
LT24.11.2021
LV24.11.2021
PL24.11.2021
RO24.11.2021
RS24.11.2021
SE24.11.2021
SM24.11.2021
BG24.02.2022
NO24.02.2022
GR25.02.2022
IS24.03.2022
PT24.03.2022
Former [2022/33]AT24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
LT24.11.2021
LV24.11.2021
PL24.11.2021
RS24.11.2021
SE24.11.2021
SM24.11.2021
BG24.02.2022
NO24.02.2022
GR25.02.2022
IS24.03.2022
PT24.03.2022
Former [2022/25]AT24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
LT24.11.2021
LV24.11.2021
PL24.11.2021
RS24.11.2021
SE24.11.2021
BG24.02.2022
NO24.02.2022
GR25.02.2022
IS24.03.2022
PT24.03.2022
Former [2022/24]AT24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
LT24.11.2021
LV24.11.2021
PL24.11.2021
RS24.11.2021
SE24.11.2021
BG24.02.2022
GR25.02.2022
IS24.03.2022
PT24.03.2022
Former [2022/23]AT24.11.2021
ES24.11.2021
FI24.11.2021
HR24.11.2021
LT24.11.2021
LV24.11.2021
PL24.11.2021
RS24.11.2021
BG24.02.2022
PT24.03.2022
Former [2022/22]AT24.11.2021
FI24.11.2021
LT24.11.2021
RS24.11.2021
BG24.02.2022
Former [2022/21]AT24.11.2021
RS24.11.2021
BG24.02.2022
Former [2022/19]BG24.02.2022
Documents cited:Search[A]US2012202793  (SWEETNAM PAUL [US], et al) [A] 1-15* claim - *;
 [A]WO2014055996  (KADMON CORP LLC [US]) [A] 1-15 * claim - * * page 142; table 1; compound 166 *
by applicant   - T. L. GILCHRIST, Comprehensive Organic Synthesis, Academic Press, vol. 7, pages 748 - 750
    - G. W. H. CHEESEMAN; E. S. G. WERSTIUK, Advances in Heterocyclic Chemistry,, Academic Press, vol. 22, pages 390 - 392
    - T. HIGUCHI; V. STELLA, "Pro-drugs as Novel Delivery Systems", ACS Symposium Series, vol. 14
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.